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Several relatively specific chromosomal translocations are known to be associ- 
ated with particular human cancers (1-3). One of these, the Philadelphia trans- 
location, t(9;22) (q34;ql 1) is observed in over 90% of chronic myelocytic leuke- 
mias (CML) 1 (3). Translocation of the ql 1 to qter segment of chromosome 22 
to chromosome 9 results in a deleted form of chromosome 22, referred to as the 
Philadelphia (Ph') chromosome (4).  Recently, we have localized a  human onco- 
gene, c-abl, on chromosome 9 (q34 to qter) (5) and demonstrated its translocation 
to chromosome 22q-  (the  Ph'  chromosome) in CML (6).  Because of the small 
size of the segment  of chromosome 9  that  translocates to chromosome 22  (6) 
and the localization of immunoglobulin k light chain sequences on chromosome 
22  (7),  c-abl  appears  to  map  in  close  proximity  to  k  sequences  in  the  Ph' 
chromosome. 
Another acute transforming retrovirus,  the Simian  sarcoma virus (SSV),  is a 
genetic  recombinant  between  a  nontransforming  retrovirus  and  cellular  se- 
quences of woolly monkey origin (8, 9). The SSV transforming gene, v-sis, and 
its human cellular homologue, c-sis, have been molecularly cloned (8-10), and c- 
sis has been localized on the q  arm of chromosome 22 (11,  12).  In the present 
study, we report the localization of c-sis on the ql 1 to qter segment of chromo- 
some 22 and its translocation from chromosome 22 to chromosome 9 in CML. 
Materials and Methods 
Cells.  Cell  lines,  propagated in  Dulbecco's modified Eagle's medium supplemented 
with  10% calf serum, included NIH/3T3 mouse cells and a human cell line, A673 (5). 
Somatic cell hybrids containing full complements of either mouse or Chinese hamster 
chromosomes and a limited number of human chromosomes were derived by fusion of 
either mouse or Chinese hamster cells with leukocytes from different CML patients or 
from normal donors (Table I); details concerning their origin and initial characterization 
have been previously reported (13, 14). 
Preparation  of a Human  c-sis Probe (c-sis Bt.7).  A cosmid clone with a cellular insert of 
30 kb containing v-sis-homologous sequences was isolated from a library of human lung 
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carcinoma DNA (15) using, as a probe, a 1.2 kb PstI v-s/s restriction fragment in pBR322 
(8), generously provided by K. Robbins and S. A. Aaronson. Isolation of a 1.7 kb BamHl 
v-s/s-homologous restriction fragment from the cosmid clone was performed according to 
previously described methods (I 5). 
Molecular Hybridization.  Restriction enzymes were purchased from New England  Bio- 
labs, Beverly,  MA and Bethesda Research Laboratories, Rockville,  MD and were used 
according to the suppliers'  specifications.  DNA were digested with restriction enzymes, 
subjected to electrophoresis through 0.75% agarose gels, and transferred to nitrocellulose 
essentially as described by Southern (16). Nick translation  of probes and filter hybridiza- 
tion were as described (15). Specific activity of the probes was 2-5 ×  10  s cpm/#g. After 
hybridization,  filters were washed under high stringency  conditions (10% standard saline 
citrate, 65 °C) and exposed to XAR-2 film (Eastman Kodak Co., Rochester, NY) for up to 
5 d  at  -70°C  with  Dupont  Lightning  Plus  intensifying  screens  (Dupont  Instruments, 
Wilmington,  DE). 
Results 
To prepare a probe suitable for identification of somatic cell hybrids containing 
human c-s/s sequences, a previously described (15) cosmid library of human lung 
carcinoma  DNA was screened for clones containing  sequences homologous to 
the 1.2 kb PstI v-s/s probe. As shown in Fig. 1, a single cosmid clone was obtained 
containing a  30 kb cellular  insert with v-s/s-homologous cellular sequences.  By 
restriction endonuclease analysis this clone was shown to correspond to a previ- 
ously  described  v-s/s-homologous  human  sequence,  designated  c-sis  (12).  For 
generation of a c-s/s-specific probe, a  single  1.7 kb BamHl fragment, possessing 
strong homology to v-s/s (c-s/s B~.7), was isolated from the cosmid cellular DNA 
insert. 
Human and mouse control cellular DNA were digested with Sst-I and analyzed 
for homology to the above described c-sis Bi.7 probe. As shown in Fig. 1, a single 
mouse cellular restriction fragment of around 10.0 kb (lane B) is detected, while 
the  only human  c-sis  B~.7 cross-reactive  Sst-I  restriction  fragment  is  3.6  kb in 
length (lane C). The size of the latter restriction  fragment corresponds to that 
predicted on the basis of the human c-sis restriction map shown in Fig. 1. Cellular 
DNA from a mouse × human somatic cell hybrid, PgMe-25NU, previously shown 
to have chromosome 22 as its only human component (14), contains the 3.6 kb 
human c-s/s B1.7 cross-reactive Sst-I restriction fragment (lane A), thus confirming 
the mapping  of c-sis  on chromosome  22.  Localization of c-sis to the region of 
chromosome 22 (ql 1 to qter) which is translocated to chromosome 9 in CML, is 
established by the absence of c-sis-homologous sequences from hybrid WESP-2A 
(lane  D),  which  contains  chromosome  22q-  (the  Ph'  chromosome)  but  lacks 
detectable amounts of chromosomes 9, 22, or 9q+ (5). 
To independently  show the  localization  of c-s/s on chromosome  22  (ql 1 to 
qter)  and  demonstrate  its translocation  to chromosome  9  in  CML,  a  series of 
Chinese hamster  ×  human  somatic cell hybrids were analyzed  for human  c-sis 
sequences. As shown in Fig.  1, lanes E and F, the only c-s/s B1.7 cross-hybridizing 
Sst-I restriction fragment in Chinese hamster cellular DNA is around 2.7 kb in 
size and  thus clearly resolved from the  3.6  kb human  Sst-I  fragment.  Hybrid 
1CB-17aNU,  which  contains  chromosome  22q-,  lacks  detectable human  c-s/s 
sequences (lane F), while a  second hybrid,  14CB-21A, containing  chromosome 
9q+ but not chromosome 9 or 22 (13), is positive for human c-s/s sequences (lane GROFFEN  ET  AL.  11 
FIGURE  1.  Localization of human c-s/s on chromosome 22 (ql I to qter) and its translocation 
to chromosome 9 in CML. SstI-digested cellular DNA (10 t~g/lane) were electrophoresed on 
0.7% agarose gels, blotted to nitrocellulose, and hybridized to the c-s/s BL~ probe shown in the 
lower portion of the figure. Cell lines analyzed are described in Table I and include PgMe25Nu 
(A), NIH/3T3 (B), A673 (C), WESP 2A (D), 14CB21A (E),  1CB17ANu (F). The positions of 
single mouse,  human,  and Chinese hamster  c-s/s BL~ homologous SstI restriction fragments 
are shown.  Hind Ill-digested DNA, included as a molecular weight marker, is shown on the 
left side of the figure. In the lower portion of the figure, the restriction map of the 30  kb 
cellular insert from the v-s/s cross-reactive cosmid clone of MboI<ligested human lung carci- 
noma DNA is shown. MboI (Mbo) sites indicate the ends of the insert; the positions of XbaI 
(Xba) and Sstl (Sst) restriction sites are shown for purposes of orientation of this clone with 
the more detailed previously published restriction maps of c-s/s (10).  The position of a single 
3.6 kb human SstI restriction fragment overlapping with the 1.7 kb BamHl restriction fragment 
(BI.7), used as a c-sis-specific  probe for analysis of somatic cell hybrids, is also shown. 
E).  Finally, hybrid  10CB-23B,  which contains chromosome 9  in the absence of 
detectable 22,  9q+,  or 21q-,  lacks human c-sis (Table  I). As internal controls, 
each of the above hybrids were also analyzed for c-abl, a marker for the portion 
of chromosome 9  translocated  to  chromosome  22  in  CML  (6),  and  for  AK1, 
which  maps  near  the  breakpoint  but  within  the  nontranslocated  portion  of 
chromosome 9 (Table I). 
Discussion 
Several of the human cellular homologues of viral oncogenes studied to date 
including c-abl  (5,  6),  c-sis (11,  12),  c-fes (5,  17), and c-mos  (18,  19) have been 
localized on human chromosomes frequently involved in translocations associated 
with specific human cancers.  One of these, c-myc,  is translocated from chromo- 12  c-sis  TRANSLOCATION  IN  CHRONIC  MYELOCYTIC  LEUKEMIA 
TABLE  I 
Translocation  of c-sis  from Chromosome  22 to Chromosome  9 in Chronic Myelocytic Leukemia 
Cell line  AK1 
Human chromosomes  Oncogenes 
9  22  9q+  22q-  c-abl  c-sis 
Mouse NIH/3T3  NT  ...... 
Human A673  NT  +  +  +  +  +  + 
Mouse ×  human hybrid 
PgMe-25NU  -  -  +  -  -  -  + 
WESP-2A  ....  +  +  - 
Chinese hamster x  human hybrid 
10CB-23B  +  +  -  -  -  +  - 
14CB-21A  +  -  -  +  -  -  + 
1CB-17a NU  ....  +  +  - 
PgMe-25NU cells contain chromosome 22 as their only human component, while each of the other 
five hybrid  clones contain a  few human chromosomes in addition  to those relevant to  the t(9;22) 
(q34;ql 1) translocation (13,  14).  Identification of hybrid clones containing c-abl sequences (6) and 
analysis of human adenylate kinase (AK 1) enzymatic activity (6) have been previously reported. Cells 
were analyzed for human c-sis-specific sequences as described in Fig.  1. 
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FIGURE  2.  Diagrammatic representation  of the  involvement of c-abl and  c-sis in  the  Ph' 
translocation.  Chromosome  banding  patterns  are  as  previously  shown  by  Yunis  (3);  map 
positions of ACONS, AK3, and AKI are as previously reported (24, 25). Localization ofc-abl 
within the terminal portion of chromosome 9  (q34), which is translocated to chromosome 22 
in  CML,  is as  described  by  de  Klein  et  al.  (6)  while  localization  of c-sis in  the  region  of 
chromosome 22  (ql 1  to qter)  translocated  to  chromosome 9  is based on  the results of the 
present study. GROFFEN  ET  AL.  13 
some 8  to chromosomes  14,  2,  or 22,  each of which contain immunoglobulin 
sequences, in Burkitt's lymphoma (1,  19-21). Similarly, c-abl maps on the region 
of chromosome 9  which translocates to chromosome 22  in CML (5,  6).  Other 
translocations, such as the t(15; 17) reciprocal transiocation associated with acute 
promyelocytic leukemia (3), involve regions to which human cellular oncogenes 
(in  this case  c-fes)  have  been  mapped  (22),  but  appear  to  be  independent of 
immunoglobulin sequences. The present demonstration that c-sis is translocated 
from chromosome 22  to chromosome 9  in CML raises the possibility that c-sis 
rather than c-abl may be involved in CML. Resolution of these alternatives will 
require a  determination of the proximity of these genes to the breakpoints in 
chromosomes 22  and  9,  respectively, and  analysis of the  expression  of their 
transcriptional and translational products in CML cells. 
In  addition  to  possible  implications regarding  the  cause  of CML and  the 
significance of the associated t(9;22) (q34;ql 1) translocation, the localization of 
c-sis within the translocated region of chromosome 22 (Fig. 2) provides a unique 
molecular marker for studies of the more complex translocations associated with 
minority populations of CML patients. These can involve translocation of the 
ql 1 to qter region of chromosome 22 to chromosomes other than chromosome 
9,  or  can  in  some instances involve more complex rearrangements including 
three  or  occasionally even  four or  five chromosomes (23).  Analysis of these 
translocations using c-abl and c-sis  probes should allow a  determination of the 
critical translocation event resulting in the generation of CML. 
Summary 
By analysis of a series of somatic cell hybrids derived by fusion of either mouse 
or  Chinese  hamster  cells  with  leukocytes  from  different  chronic  myelocytic 
leukemia (CML) patients or from normal donors, we have localized the human 
oncogene, c-sis, on the q 11 to qter segment of chromosome 22 and demonstrated 
its translocation from chromosome 22 to chromosome 9 (q34) in CML. 
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